<DOC>
	<DOCNO>NCT01269125</DOCNO>
	<brief_summary>The investigator attempt establish rationale Gonadotropin Releasing Hormone-agonist ( GnRH-a ) administration , post-laparoscopically , woman mild endometriosis ( stage II , accord AFS ) undergo IVF-ET procedure . Since GnRH-a reduces cytokine 's concentration serum ( Iwabe et al. , 1998 ; Iwabe et al. , 2003 ) peritoneal fluid woman endometriosis ( Taketani et al. , 1992 ) investigator hypothesize GnRH-a reduces also cytokine 's concentration follicular fluid action may improve oocyte quality fertility woman .</brief_summary>
	<brief_title>GnRH-a Pregnancy Rate In Vitro Fertilization ( IVF ) Cycles .</brief_title>
	<detailed_description>This prospective , randomized study control group carry Department Obstetrics Gynecology , Ioannina University School Medicine ( Ioannina , Greece ) . The study population consist 120 infertile woman ( year sexual attempt ) , age 29-38 year , laparoscopically document endometriosis refer In Vitro Fertilization ( IVF ) Unit Department infertility treatment 7-years period ( May 2004 September 2010 ) . In addition , current study , use 60 woman tubal infertility , document laparoscopy , without prior history ovarian surgery , hydrosalpinx , and/or endometriosis control group . This group use see endometriosis affect woman 's fertility . The participant 's enrolment make three follow author A.K. , K.Z. , M.P . During laparoscopy , endoscopist document extension disease , distribution endometriotic lesion peritoneal cavity , presence/absence active endometriotic lesion ( red vascularize area ) . All visible active endometriotic lesion cauterize bipolar diathermy . Women sonographic evidence ovarian endometrioma &gt; 2 cm mean diameter , early follicular phase serum Follicular Stimulating Hormone ( FSH ) level &gt; 12 mIU/ml exclude study . Cases male factor infertility define concentration motile sperm le 10 x 106 /ml sperm normal morphology le 4 % ( Kruger , strict criterion ) also exclude study . All woman decide undergo IVF-Embryo Transfer ( ET ) attempt randomize two group accord administration GnRH-a treatment , post-laparoscopy . The randomization perform accessing central internet-based randomization program . The random allocation sequence assignment participant intervention make first author study ( A.K. ) . The first group ( Group A ) consist 60 woman receive depot preparation GnRH-a , 3.75 mg s.c , ( leuprolide , Daronda depot , 3.75 , Abbott , Hellas ) every 28 day three injection . The investigator prefer pre-treat study patient long-acting GnRH-a period 3 month already report pregnancy rate IVF-ET similar patient endometriosis pre-treated GnRH-a 10 90 day great 90 day ( Caruso 1997 ; Surrey et al. , 2002 ) . In group , laparoscopies perform 4 6 month prior cycle initiation infertility . The second group ( Group B ) consist 60 infertile woman endometriosis receive long-acting GnRH-a . All woman comparable regard mean age , BMI , duration infertility . All woman control group B , underwent control ovarian hyperstimulation ( COH ) down-regulation GnRH-a ( leuprolide , 20 IU/day , Daronda , 2.8 , Abbott , Hellas ) long protocol mid-luteal start . Administration recombinant follicle stimulate hormone ( rFSH , Gonal-F , Serono , Geneva , Switzeland ) start least 14 day leuprolide therapy serum estradiol ( E2 ) less 100 pmol/l thickness endometrium less 5mm . Down-regulation woman group A initiate 30 45 day third GnRH-a injection . A start dose 150 IU follicle stimulate hormone ( rFSH , Gonal-F , Serono , Geneva , Switzerland ) adjust individually day 6 cycle accord estradiol ( E2 ) value ultrasonographic follicular measurement . An ovulatory dose human chorionic gonadotropin ( HGG ) ( Pregnyl , Organon , Oss , The Netherlands ) 5,000-10,000 IU administer I.M . mean diameter average two four follicle large 16mm plasma estradiol concentration high 1500 pmol/l . All woman provide luteal-phase support natural micronized progesterone ( Ultrogestan , Faran , Athens , Greece ) , 600 mgr daily vaginally three divide dosage , start day embryo transfer . Follicular fluid sampling , oocyte collection IVF Follicular fluid ( FF ) sample collect oocyte retrieval . From patient , follicular fluid sample first one three mature follicle , diameter 18-20mm . Tumor Necrosis Factor ( TNF ) -a , Interleukine ( IL ) -1β , IL-6 , IL-8 IL-1-ra measure FF woman ( secondary outcome measure ) . To prevent cytokine alteration , blood-free sample use . IVF perform case . The fertilization rate estimate every woman 24 hour oocyte retrieval ( primary outcome measure ) . Embryo grade transfer The embryo quality clinical pregnancy rate also primary outcome measure . Embryo development evaluate 2 day oocyte pick-up . The number blastomeres proportion embryo volume occupy fragment use evaluation . Embryos &lt; 10 % , &lt; 10-20 % , &lt; 20-30 % &gt; 30 % fragment estimate grade 1,2,3 4 , respectively . Three embryos high blastomere number best morphology transfer cycle . The remain high-grade embryos cryopreserved day . Pregnancy diagnose quantitative β-hCG , two week embryos transfer . Clinical pregnancy confirm observe fetal cardiac activity transvaginal ultrasound four week positive pregnancy test . The clinical pregnancy rate quality embryo estimate woman . The pregnancy rate define presence sonographically visualized cardiac activity per cycle initiate .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Infertility Mild endometriosis ( stage II ) ovarian endometrioma &gt; 2 cm FSH &gt; 12 mIU/ml Mail factor infertility</criteria>
	<gender>Female</gender>
	<minimum_age>29 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>cytokine</keyword>
	<keyword>endometriosis</keyword>
	<keyword>fertilization rate</keyword>
	<keyword>follicular fluid</keyword>
	<keyword>pregnancy rate</keyword>
</DOC>